Lumos Pharma Inc (NAS:LUMO)
$ 3.94 0.1 (2.6%) Market Cap: 32.01 Mil Enterprise Value: 14.68 Mil PE Ratio: 0 PB Ratio: 3.10 GF Score: 47/100

NewLink Genetics Corp at Bank of America Merrill Lynch Health Care Conference Transcript

May 16, 2019 / 03:40PM GMT
Release Date Price: $14.58
Alec Warren Stranahan
BofA Merrill Lynch, Research Division - Research Analyst

I think we can get the session started. My name is Alec Stranahan, I'm an associate on Ying Huang's team at Bank of America, covering large-cap biotech. I have the pleasure today of introducing Dr. Charles Link, Co-Founder and CEO of NewLink Genetics. Welcome to the conference.

Charles J. Link
NewLink Genetics Corporation - Co-Founder, Chairman, CEO & Chief Scientific Officer

Thank you.

Alec Warren Stranahan
BofA Merrill Lynch, Research Division - Research Analyst

And he'll start with an introduction to the company, go through the slides, and then we'll open it up for Q&A.

Charles J. Link
NewLink Genetics Corporation - Co-Founder, Chairman, CEO & Chief Scientific Officer

Well, thank you for having us here at the conference. My slides are not advancing. Okay. I will be making some forward-looking statements today so I refer you to the appropriate regulatory documents.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot